David E. Sveen - 13 Jun 2023 Form 4 Insider Report for HESKA CORP (HSKA)

Role
Director
Signature
/s/ By: Catherine Grassman For: David E. Sveen
Issuer symbol
HSKA
Transactions as of
13 Jun 2023
Transactions value $
-$5,169,720
Form type
4
Filing time
14 Jun 2023, 18:27:50 UTC
Previous filing
06 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSKA Common Stock Disposed to Issuer -$2.6M -21.7K -100% $120.00 0 13 Jun 2023 Direct F1
transaction HSKA Common Stock Disposed to Issuer -$1.71M -14.3K -100% $120.00 0 13 Jun 2023 by Bethany Creek F1, F2
transaction HSKA Common Stock Disposed to Issuer -$857K -7.14K -100% $120.00 0 13 Jun 2023 by Lindberg Capital F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David E. Sveen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer on the effective date of the merger.
F2 Represents shares held by Bethany Creek Partners, LP. Dr. Sveen is a general partner of and an investor in Bethany Creek Partners, LP.
F3 Represents shares held by Lindberg Capital Partners, LP. Dr. Sveen is a general partner of and an investor in Lindberg Capital Partners, LP.